Back to Search
Start Over
Efficacy and Safety of Tirabrutinib and Idelalisib With or Without Obinutuzumab in Relapsed Chronic Lymphocytic Leukemia
- Source :
- HemaSphere, Vol 6, Iss 6, p e729 (2022)
- Publication Year :
- 2022
- Publisher :
- Wiley, 2022.
- Subjects :
- Diseases of the blood and blood-forming organs
RC633-647.5
Subjects
Details
- Language :
- English
- ISSN :
- 25729241 and 00000000
- Volume :
- 6
- Issue :
- 6
- Database :
- Directory of Open Access Journals
- Journal :
- HemaSphere
- Publication Type :
- Academic Journal
- Accession number :
- edsdoj.b0aae89c3a4826bbe95658972ef6d0
- Document Type :
- article
- Full Text :
- https://doi.org/10.1097/HS9.0000000000000729